Endocyte [clinicaltrials_resource:d231824290a69a6d5fd34132884c5ec3]
Romnee Clark, MD [clinicaltrials_resource:088b5d0f6e05411a60ab05da48e058a4]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Binh Nguyen, MD, PhD [clinicaltrials_resource:313759b5e9c42653ef8bc20a141ab9f6]Romnee Clark, MD [clinicaltrials_resource:334d534b6d4e9e40af1f22bbd74ce3c7]Richard A. Messmann, MD, MHS, MSc [clinicaltrials_resource:3c994171ae38941d5cb109ed4d776c31]Romnee Clark, MD [clinicaltrials_resource:4daff9e271cafbd56a2d30c78d6f5384]Richard A Messmann, MD, MHS, BSc [clinicaltrials_resource:50591665adcbd66cd89324d9705c036a]Binh Nguyen, MD, PhD [clinicaltrials_resource:80f2f37a4fe53cefd9f35fd7900bacd7]Richard A Messmann, MD, MHS, MSc [clinicaltrials_resource:9c0f2e5cfe2690945c61be016f91af01]Binh Nguyen, MD [clinicaltrials_resource:b23a76a9c35c5c611c9de5dae40c09ab]Alessandra Cesano, MD, PhD [clinicaltrials_resource:dff57cf5a37ebeb506f6580491be4334]Binh Nguyen, MD, PhD [clinicaltrials_resource:efe44c3206d1725bdd68789a98694853]
affiliation [clinicaltrials_vocabulary:affiliation]
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer [clinicaltrials:NCT00003763]Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) [clinicaltrials:NCT00308269]Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer [clinicaltrials:NCT00329368]Study of EC0225 for the Treatment of Refractory or Metastatic Tumors [clinicaltrials:NCT00441870]A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00485563]Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) [clinicaltrials:NCT00507741]Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [clinicaltrials:NCT00511485]clinicaltrials:NCT00722592Study of EC0489 for the Treatment of Refractory or Metastatic Tumors [clinicaltrials:NCT00852189]Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) [clinicaltrials:NCT01002924]clinicaltrials:NCT01170650clinicaltrials:NCT01577654Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [clinicaltrials:NCT01684098]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer [clinicaltrials:NCT01686256]A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) [clinicaltrials:NCT01688791]Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients [clinicaltrials:NCT01689636]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma [clinicaltrials:NCT01689662]Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [clinicaltrials:NCT01689714]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors [clinicaltrials:NCT01689727]Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma [clinicaltrials:NCT01689766]Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers [clinicaltrials:NCT01748864]Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) [clinicaltrials:NCT01953536]Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors [clinicaltrials:NCT01999738]A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) [clinicaltrials:NCT02049281]Phase 1 of EC1169 In Patients With Recurrent MCRPC [clinicaltrials:NCT02202447]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) [clinicaltrials:NCT00308269]Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer [clinicaltrials:NCT00329368]Study of EC0225 for the Treatment of Refractory or Metastatic Tumors [clinicaltrials:NCT00441870]A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00485563]Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) [clinicaltrials:NCT00507741]Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [clinicaltrials:NCT00511485]clinicaltrials:NCT00722592Study of EC0489 for the Treatment of Refractory or Metastatic Tumors [clinicaltrials:NCT00852189]Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) [clinicaltrials:NCT01002924]clinicaltrials:NCT01170650clinicaltrials:NCT01577654Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [clinicaltrials:NCT01684098]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer [clinicaltrials:NCT01686256]A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) [clinicaltrials:NCT01688791]Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients [clinicaltrials:NCT01689636]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma [clinicaltrials:NCT01689662]Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [clinicaltrials:NCT01689714]Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors [clinicaltrials:NCT01689727]Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma [clinicaltrials:NCT01689766]Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers [clinicaltrials:NCT01748864]Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) [clinicaltrials:NCT01953536]Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors [clinicaltrials:NCT01999738]A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) [clinicaltrials:NCT02049281]Phase 1 of EC1169 In Patients With Recurrent MCRPC [clinicaltrials:NCT02202447]
source [clinicaltrials_vocabulary:source]
Endocyte [clinicaltrials_resource:d231824290a69a6d5fd34132884c5ec3]
Bio2RDF identifier
d231824290a69a6d5fd34132884c5ec3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d231824290a69a6d5fd34132884c5ec3
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:d231824290a69a6d5fd34132884c5ec3
title
Endocyte
@en
type
label
Endocyte [clinicaltrials_resource:d231824290a69a6d5fd34132884c5ec3]
@en